Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
出版年份 2014 全文链接
标题
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 13, Issue 6, Pages 419-431
出版商
Springer Nature
发表日期
2014-05-16
DOI
10.1038/nrd4309
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Model-based drug discovery: implementation and impact
- (2013) Sandra A.G. Visser et al. DRUG DISCOVERY TODAY
- Does size matter in R&D productivity? If not, what does?
- (2013) Michael Ringel et al. NATURE REVIEWS DRUG DISCOVERY
- Phase II and Phase III attrition rates 2011–2012
- (2013) John Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Genomic responses in mouse models poorly mimic human inflammatory diseases
- (2013) Junhee Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients
- (2012) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Drug-mediated toxicity: illuminating the ‘bad’ in the test tube by means of cellular assays?
- (2012) Tewes Tralau et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial
- (2012) Dona L Fleishaker et al. ARTHRITIS RESEARCH & THERAPY
- Quantitative pharmacological analysis of antagonist binding kinetics at CRF1 receptors in vitro and in vivo
- (2011) Simeon J Ramsey et al. BRITISH JOURNAL OF PHARMACOLOGY
- A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma
- (2011) N. Barnes et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
- (2011) Paul Morgan et al. DRUG DISCOVERY TODAY
- Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches?
- (2011) Stephen T. Holgate JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Market withdrawal of new molecular entities approved in the United States from 1980 to 2009
- (2011) Zaina P. Qureshi et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Effect on perfusion chamber thrombus size in patients with atrial fibrillation during anticoagulant treatment with oral direct thrombin inhibitors, AZD0837 or ximelagatran, or with vitamin K antagonists
- (2011) Michael Wolzt et al. THROMBOSIS RESEARCH
- In-vitro assessment of platelet function
- (2011) Susanne M. Picker TRANSFUSION AND APHERESIS SCIENCE
- CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial
- (2010) A. W. R. van Kuijk et al. ANNALS OF THE RHEUMATIC DISEASES
- Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate
- (2010) Daniëlle M. Gerlag et al. ARTHRITIS AND RHEUMATISM
- The translatability of animal models for clinical development: biomarkers and disease models
- (2010) Alexandra Wendler et al. CURRENT OPINION IN PHARMACOLOGY
- Of Mice and Humans: Are They the Same?--Implications in Cancer Translational Research
- (2010) M. de Jong et al. JOURNAL OF NUCLEAR MEDICINE
- Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist
- (2010) F. G. Gervais et al. MOLECULAR PHARMACOLOGY
- The benefits and limitations of animal models for translational research in neurodegenerative diseases
- (2010) Mathias Jucker NATURE MEDICINE
- Neuropsychiatric adverse effects signal the end of the line for rimonabant
- (2010) Alexandra King Nature Reviews Cardiology
- Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation
- (2010) Lars Rasmussen et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats
- (2010) Susanne Pehrsson et al. THROMBOSIS AND HAEMOSTASIS
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- A prostaglandin D2receptor antagonist modifies experimental asthma in sheep
- (2009) M. Shichijo et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
- (2009) G. Y.H. Lip et al. EUROPEAN HEART JOURNAL
- Assessing the translatability of drug projects: what needs to be scored to predict success?
- (2009) Martin Wehling NATURE REVIEWS DRUG DISCOVERY
- Lessons from 60 years of pharmaceutical innovation
- (2009) Bernard Munos NATURE REVIEWS DRUG DISCOVERY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glutamate-based antidepressants: 20 years on
- (2009) Phil Skolnick et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation
- (2008) Nicholas W. Lukacs et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started